CVS Health Corporation (CVS)
NYSE: CVS · Real-Time Price · USD
56.12
-0.66 (-1.16%)
At close: Oct 24, 2024, 4:00 PM
56.15
+0.03 (0.05%)
After-hours: Oct 24, 2024, 5:39 PM EDT
CVS Health Stock Forecast
Stock Price Forecast
The 18 analysts with 12-month price forecasts for CVS Health stock have an average target of 75.39, with a low estimate of 60 and a high estimate of 100. The average target predicts an increase of 34.34% from the current stock price of 56.12.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for CVS Health stock from 18 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 | 6 | 6 |
| Buy | 8 | 8 | 8 | 6 | 5 | 7 |
| Hold | 7 | 7 | 7 | 7 | 7 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 21 | 21 | 21 | 19 | 18 | 18 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho | Mizuho | Buy Maintains $73 → $66 | Buy | Maintains | $73 → $66 | +17.61% | Oct 24, 2024 |
| Barclays | Barclays | Buy Maintains $82 → $75 | Buy | Maintains | $82 → $75 | +33.64% | Oct 23, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $66 → $76 | Strong Buy | Maintains | $66 → $76 | +35.42% | Oct 11, 2024 |
| Barclays | Barclays | Hold → Buy Upgrades $63 → $82 | Hold → Buy | Upgrades | $63 → $82 | +46.12% | Oct 10, 2024 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $62 → $75 | Buy | Maintains | $62 → $75 | +33.64% | Oct 8, 2024 |
Financial Forecast
Revenue This Year
373.05B
from 356.62B
Increased by 4.60%
Revenue Next Year
390.23B
from 373.05B
Increased by 4.61%
EPS This Year
6.60
from 6.47
Increased by 2.02%
EPS Next Year
7.39
from 6.60
Increased by 11.98%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 389.7B | 415.6B | 447.4B | ||
| Avg | 373.0B | 390.2B | 412.0B | ||
| Low | 357.4B | 369.3B | 389.0B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 9.3% | 11.4% | 14.7% | ||
| Avg | 4.6% | 4.6% | 5.6% | ||
| Low | 0.2% | -1.0% | -0.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 7.35 | 8.53 | 9.67 | ||
| Avg | 6.60 | 7.39 | 8.31 | ||
| Low | 6.28 | 6.89 | 7.62 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 13.6% | 29.2% | 30.8% | ||
| Avg | 2.0% | 12.0% | 12.5% | ||
| Low | -2.9% | 4.4% | 3.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.